Is fluticasone safe during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Fluticasone During Pregnancy

Fluticasone is considered compatible with pregnancy and can be safely used at recommended doses throughout pregnancy for managing allergic rhinitis and asthma. 1

Evidence-Based Safety Profile

Fluticasone has been classified as FDA Pregnancy Category B3 (according to the Therapeutic Goods Administration classification), indicating that animal studies have shown adverse effects, but adequate studies in pregnant women have not demonstrated risk to the fetus 1. The European Respiratory Society/TSANZ task force statement specifically lists fluticasone as "compatible" during pre-conception and first trimester, and "probably safe" during second and third trimesters 1.

Key safety considerations:

  • Intranasal corticosteroids: A meta-analysis concluded that intranasal corticosteroids during pregnancy do not increase the risk of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension 1.

  • Fluticasone-specific data: Studies evaluating fluticasone propionate for asthma during pregnancy found no increased risk of major congenital malformations compared to other inhaled corticosteroids, with an absolute risk of 2.4-2.7% (within normal population range) 2.

  • Expert recommendations: The American Academy of Allergy, Asthma, and Immunology advises that fluticasone nasal spray is safe to use at recommended doses throughout pregnancy for rhinitis or chronic rhinosinusitis management 3.

Clinical Decision Algorithm

  1. For women already using fluticasone before pregnancy:

    • Continue treatment if symptoms are well-controlled 3
    • Use the lowest effective dose to maintain symptom control 1
  2. For women starting treatment during pregnancy:

    • Consider budesonide as first choice (has most extensive human safety data) 1, 3
    • Fluticasone is an acceptable alternative if budesonide is not effective or available 3, 4
  3. Administration guidelines:

    • Use at the lowest effective dose 1
    • Avoid off-label formulations (such as budesonide irrigations or corticosteroid nasal drops) 3

Important Precautions

  • Dosing considerations: Animal studies showed fetal toxicity at high doses, including embryonic growth retardation and cleft palate 5, so maintaining the lowest effective dose is important.

  • Monitoring: No special monitoring is required, but regular prenatal care should continue as scheduled.

  • Concomitant medications: Avoid combining with potent CYP3A4 inhibitors like ketoconazole or ritonavir during pregnancy, as these can increase systemic exposure to fluticasone 5.

Benefits vs. Risks

The benefits of treating rhinitis or asthma symptoms during pregnancy typically outweigh the theoretical risks of appropriate intranasal corticosteroid use 3. Untreated respiratory conditions may negatively impact:

  • Maternal quality of life
  • Sleep quality
  • Oxygen delivery to the fetus (in the case of asthma)

Importantly, alternative treatments like oral decongestants should be avoided during pregnancy, especially in the first trimester, due to potential associations with congenital malformations 1, 3.

In conclusion, fluticasone can be safely used during pregnancy when clinically indicated, with preference for maintaining established effective therapy rather than switching medications during pregnancy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study.

The journal of allergy and clinical immunology. In practice, 2015

Guideline

Management of Allergic Rhinitis During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety of intranasal corticosteroid sprays during pregnancy: an updated review.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.